How many studies have been conducted on Vascular Endothelial Growth Factor C?

BiohacksAI has indexed 300 PubMed studies on Vascular Endothelial Growth Factor C, including 7 randomized controlled trials (RCTs). 45% of studies involve human subjects.

What are the main research areas for Vascular Endothelial Growth Factor C?

The primary research domains for Vascular Endothelial Growth Factor C are 🔬 Oncology, ⏳ Longevity & Aging, 🫘 Kidney. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Vascular Endothelial Growth Factor C

A vascular endothelial growth factor that specifically binds to VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2 and VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. In addition to being an angiogenic factor it can act on LYMPHATIC VESSELS to stimulate LYMPHANGIOGENESIS. It is similar in structure to VASCULAR ENDOTHELIAL GROWTH FACTOR D in that they both contain N- and C-terminal extensions that were not found in other VEGF family members.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 51.4

Research Domains

Vascular Endothelial Growth Factor C has been studied across 16 research domains including 🔬 Oncology, ⏳ Longevity & Aging, 🫘 Kidney, 🔬 Inflammation, 🧬 Hormones. The primary research focus is 🔬 Oncology with 65% of studies addressing this area.

Loading evidence profile...

This evidence profile for Vascular Endothelial Growth Factor C is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.